Filing Details
- Accession Number:
- 0001547522-16-000255
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-07-07 16:46:49
- Reporting Period:
- 2016-07-07
- Filing Date:
- 2016-07-07
- Accepted Time:
- 2016-07-07 16:46:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 811641 | Immucell Corp | ICCC | In Vitro & In Vivo Diagnostic Substances (2835) | 010382980 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1136546 | H Joseph Crabb | C/O Immucell Corporation 56 Evergreen Drive Portland ME 04103 | Vp & Chief Scientific Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.10 Per Share | Disposition | 2016-07-06 | 900 | $6.60 | 108,837 | No | 4 | S | Direct | |
| Common Stock, Par Value $0.10 Per Share | Disposition | 2016-07-06 | 300 | $6.59 | 108,537 | No | 4 | S | Direct | |
| Common Stock, Par Value $0.10 Per Share | Disposition | 2016-07-06 | 300 | $6.58 | 108,237 | No | 4 | S | Direct | |
| Common Stock, Par Value $0.10 Per Share | Disposition | 2016-07-06 | 300 | $6.57 | 107,937 | No | 4 | S | Direct | |
| Common Stock, Par Value $0.10 Per Share | Disposition | 2016-07-06 | 326 | $6.57 | 107,611 | No | 4 | S | Direct | |
| Common Stock, Par Value $0.10 Per Share | Disposition | 2016-07-06 | 300 | $6.59 | 107,311 | No | 4 | S | Direct | |
| Common Stock, Par Value $0.10 Per Share | Disposition | 2016-07-07 | 6 | $6.59 | 107,305 | No | 4 | S | Direct | |
| Common Stock, Par Value $0.10 Per Share | Disposition | 2016-07-07 | 200 | $6.53 | 107,105 | No | 4 | S | Direct | |
| Common Stock, Par Value $0.10 Per Share | Disposition | 2016-07-07 | 59 | $6.55 | 107,046 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The transactions reported herein have been effectuated pursuant to a plan implemented by the reporting person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
Billionaire Hedge Funds
